The organizational set up of various functionaries in Drugs and Control Administration are broadly classified into two wings.

    1. Enforcement Wing 2. Laboratory Wing.

    Enforcement Wing performs the functions of enforcement of the above legislations in the State and Laboratory Wing performs the Test/Analysis of various Drugs/Cosmetics samples sent for analysis and issues the Certificate of Test/Analysis.

    In 1976, FDA was carved out from the Directorate of Medical and Health, headed by an IPS Officer till 1981. Drugs Control Administration, A.P was separated from the office of the Drugs Controller & State Food Health Authority in the year 1981 and was made an independent Department headed by Director, DCA till 1996.

    In Aug 1996, Govt. had posted an IPS officer of the rank of Inspector General of Police, Drugs and Copyright to head the DCA. Subsequently this post was upgraded to ADGP/DGP level as the HOD.

    After the bifurcation of erstwhile Andhra Pradesh state, the Drugs Control Administration department of Telangana State was setup on 02.06.2014.

  • Spurious Anti cancer drug manufacturer caught by the officials of Drugs Control Administration, Telangana and seized medicines worth Rs. Four crore thirty five lakhs at Macha Bollaram
  • US FDA officials visited Drugs Control Administration, Telangana office on 02nd November, 2023
    • DCA Toll Free Number 18005996969 functional from 10.30 am to 5.00 pm on all working days
  • Advisory Procurement and testing of the raw materials Glycerin and Propylene Glycol by the Cough Syrup manufacturers
  • Circular Memo for ensuring the use of authentic Indian Pharmacopoeia, IP Reference Standards IPRS and impurity standards for quality testing of drugs.
  • Procedure for submission of cough syrups to be exported by manufacturer, exporter directly to Central, NABL accredited state testing laboratories for testing purpose.
  • Implementation of regulation of pre shipment document verification, physical inspection, QC testing, issuance of CRIA for pharmaceuticals to be exported to The Gambia by Medicines Control Agency
  • STOP USE NOTICE RECALL CIRCULAR Thyronorm Tablets Thyroxin Sodium Tablets B No AEJ0713
  • Application for registration certificate for medical devices in Form MD41- Procedure to be followed
  • Direction under Section 33P of the Drugs and Cosmetics Act 1940 for issuance of clarification on Stem Cell derived products as defined under New Drugs and Clinical Trial Rules, 2019 - Communicated.
    • Applications for grant of manufacturing licence for Cosmetics has to be submitted as per the Cosmetics Rules 2020 effective from 15th December 2020
  • Hand Sanitizers - Requirements to be met by the applicant firms
  • Circular issued to Industrial Oxygen Manufacturers in Telangana regarding granting of permissions to ensure adequate supply and availability of Medical Oxygen in view of COVID-19
  • Advisory for maintaining safe and adequate blood supply during the pandemic outbreak of COVID-19 issued to Blood Banks in Telangana State
  • Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs
  • Condition of licence for undertaking on brand or trade names of drugs under Drugs and Cosmetics Rules, 1945
  • Guidance regarding uploading of manufacturing site and formulations data on SUGAM Portal

    • COVID-19 Status

    odlshelpdesk.ts@gmail.com

    Main Menu

    Public Services

      Your are Visitor #441450